Unanswered Questions Surround Trump’s Health Checkup

Questions persist about former President Trump’s health following a recent examination. Trump’s physician, Dr. Sean P. Barbabella, provided an optimistic report stating Trump was in ‘excellent health’ with strong cardiac, pulmonary, neurological, and overall physical function. However, the examination left several questions unanswered.

The memo from Dr. Barbabella was released late on a Friday night, shortly after Trump’s physical took place. Despite the report’s positive tone, it did not address concerns about bruising on Trump’s hands, drowsiness during certain public events, and swelling in his lower legs. Dr. Barbabella attributed the bruising to ‘minor soft tissue irritation’ due to frequent handshaking and the side effects of aspirin therapy.

When a President’s physicians start citing ‘AI cardiac age’ metrics and explaining bilateral bruising from ‘frequent handshaking,’ the line between medical documentation and political messaging disappears, said Vin Gupta, a pulmonologist and public health expert, on the social platform X.

Trump’s medical history has often been shrouded in secrecy, drawing criticism from those who accuse him of obscuring the full picture of his health. Critics question the use of ‘AI-enhanced’ electrocardiogram results that claimed his cardiac age was 14 years younger than his chronological age. Healthcare professionals pointed out that this tool is not typically used in a clinical setting and is not recognized as a valid diagnostic finding.

Jonathan Reiner, formerly Vice President Cheney’s cardiologist, questioned why Trump needed multiple CT scans of his coronary arteries. He wrote on X, We don’t typically scan patients 6 months later unless there is concern about a finding on the initial scan. What prompted the repeat CT? Reiner also noted that while the latest report mentioned improvement in ankle edema, last year’s exam did not reference this condition.

These ongoing questions about Trump’s health come amidst regular updates in the health care sector. Noteworthy developments include a $50 million investment from the Coalition for Epidemic Preparedness Innovations (CEPI) in developing a vaccine against the Bundibugyo strain of Ebola. Meanwhile, protests erupted in Kenya against an Ebola quarantine center at Laikipia Air Base.

On the cancer front, a personalized mRNA vaccine by Moderna and Merck shows promise in reducing melanoma recurrence, with studies tracking its effect over five years in patients with Stage 3 melanoma across the U.S. and Australia.

Legislative hearings are also making headlines. The Senate HELP Committee will hear issues regarding ‘gender transition procedures on minors.’ Other hearings will cover COVID-19 vaccines, scientific publications, foreign drug dangers, and medicine-related intellectual property. The House Appropriations subcommittee will discuss FY 2027 bills related to Labor, Health and Human Services, and Education.